鼓室内注射抗氧化剂洗脱微颗粒对小鼠模型顺铂耳毒性的耳保护作用
该研究为基础科学实验,将18只小鼠分为三组,比较鼓室内注射N-乙酰半胱氨酸洗脱微颗粒与空微颗粒对全身顺铂耳毒性的保护效果。结果显示,接受N-乙酰半胱氨酸微颗粒注射并接受三个周期腹腔顺铂注射的耳阈值偏移与未接受顺铂的配对耳相似;而接受空微颗粒注射并接受顺铂的小鼠阈值较接受N-乙酰半胱氨酸微颗粒及顺铂的小鼠升高。结论为鼓室内N-乙酰半胱氨酸微颗粒注射在顺铂暴露小鼠中提供了功能性耳保护。
要点
- 鼓室内注射N-乙酰半胱氨酸微颗粒可减轻顺铂引起的小鼠听阈偏移。
- 接受空微颗粒加顺铂的小鼠听阈较接受N-乙酰半胱氨酸微颗粒加顺铂的小鼠升高。
- 该研究为小鼠基础实验,共18只小鼠,分三组。
核心结论
- 鼓室内N-乙酰半胱氨酸微颗粒注射在顺铂暴露小鼠中提供了功能性耳保护。
研究设计与样本
- 基础科学实验,18只小鼠分为三组:健康对照空微颗粒组、顺铂空微颗粒组和顺铂N-乙酰半胱氨酸微颗粒组。
主要发现
- 接受鼓室内N-乙酰半胱氨酸注射并接受三个周期腹腔顺铂注射的耳阈值偏移与未接受顺铂的配对耳相似。
- 接受鼓室内空微颗粒注射并接受腹腔顺铂注射的小鼠听阈较接受鼓室内N-乙酰半胱氨酸注射并接受顺铂的小鼠升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cisplatin is a chemotherapeutic agent with the undesirable side effect of ototoxicity. Transtympanic injections of antioxidant formulations may provide local otoprotection. We tested a novel antioxidant-eluting microparticle for its otoprotective capability from systemic cisplatin as measured by cochlear electrophysiology. STUDY DESIGN: Basic science. SETTING: Translational research laboratory. METHODS: Eighteen mice were assigned to three groups. All mice underwent baseline click-evoked auditory brainstem response (ABR) audiometry and right ear microparticle injections before beginning 42-day intraperitoneal administration regimens of either saline (healthy control empty microparticle [HCEMP] group) or cisplatin (cisplatin empty microparticle [CEMP] group and cisplatin N-acetylcysteine microparticle [CNAC] group). These regimens consisted of three 4-day cycles of intraperitoneal saline or cisplatin administration followed by 10 rest days. HCEMP and CEMP received right-sided transtympanic empty microparticles, and CNAC received transtympanic N-acetylcysteine eluting microparticles. On day 43, all mice underwent posttreatment ABR. ABR thresholds and threshold shifts were analyzed with mixed-effects models and Tukey's post hoc tests and were compared across pretreatment/posttreatment ears, treatment groups, and injected and non-injected ears. RESULTS: We found that threshold shifts in the ears that received a transtympanic injection of N-acetylcysteine and three cycles of intraperitoneal cisplatin were similar to the paired ears of mice that received no cisplatin. Mice that received a transtympanic injection without N-acetylcysteine and intraperitoneal cisplatin had increased thresholds compared to mice that received a transtympanic injection of N-acetylcysteine and cisplatin. CONCLUSION: Transtympanic N-acetylcysteine microparticle injections provided functional otoprotection in cisplatin-exposed mice.
引用
- Smith EM, Boixo C, Hoffman L, et al. Transtympanic Injection of Antioxidant-Eluting Microparticles for Otoprotection From Cisplatin Toxicity in a Mouse Model. Otolaryngol Head Neck Surg. 2025. PMID: 40801201. doi:10.1002/ohn.70002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。